4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000027
CHIEF OPERATING OFFICER sold 3,000 shares at an average $76.34 ($229,013)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2024-07-01 | Sale 10b5-1 | −1,226 | $75.75 | $92,875 | 212,277 | D: show line 1 in the form |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-07-01 | Sale 10b5-1 | −1,663 | $76.71 | $127,566 | 210,614 | D: show line 2 in the form |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-07-01 | Sale 10b5-1 | −111 | $77.22 | $8,571 | 210,503 | D: show line 3 in the form |
| Open-market sales · 3,000 sh · avg $76.34 · $229,013 | |||||||
Loading xslF345X05/wk-form4_1719951391.xml…